• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管平滑肌细胞中参与血管紧张素II、缓激肽、降钙素基因相关肽(CGRP)和神经肽Y代谢的蛋白酶。

Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells.

作者信息

Mentlein R, Roos T

机构信息

Anatomisches Institut, Universität Kiel, Germany.

出版信息

Peptides. 1996;17(4):709-20. doi: 10.1016/0196-9781(96)00066-6.

DOI:10.1016/0196-9781(96)00066-6
PMID:8804084
Abstract

To understand the regulation of the vasoactive peptides bradykinin, angiotensin II, calcitonin gene-related peptide (CGRP), and neuropeptide Y (NPY), their proteolytic catabolism by cultured rat aortic vascular smooth muscle cells and A7r5 cells was investigated. Endopeptidase-24.11 (EC 3.4.24.11, CD 10) was responsible for the final inactivation of bradykinin, angiotensin II, and CGRP, but not of NPY, which was degraded by a different metallo-endopeptidase. Exopeptidases, namely the aminopeptidases A (EC 3.4.11.7), N (EC 3.4.11.2, CD 13), and P (EC 3.4.11.9) and the carboxypeptidases M (EC 3.4.17.12) and P (EC 3.4.17.16), were important for their differential, receptor subtype-specific activation or inactivation. Aminopeptidase A and N generated angiotensins III and IV from angiotensin II. Aminopeptidase P liberated the terminal amino acids from bradykinin and NPY, yielding the Y2 receptor specific-agonist NPY(2-36). Carboxypeptidase P produced AT II(1-7) and carboxypeptidase M produced the BK1 receptor agonist [des-Arg9]bradykinin. Thus, peptidases at the surface of vascular smooth muscle cells exert a complex influence on the level of biologically active vasoactive peptides.

摘要

为了解血管活性肽缓激肽、血管紧张素II、降钙素基因相关肽(CGRP)和神经肽Y(NPY)的调节机制,研究了培养的大鼠主动脉血管平滑肌细胞和A7r5细胞对它们的蛋白水解代谢作用。内肽酶-24.11(EC 3.4.24.11,CD 10)负责缓激肽、血管紧张素II和CGRP的最终失活,但不负责NPY的失活,NPY由另一种金属内肽酶降解。外肽酶,即氨肽酶A(EC 3.4.11.7)、N(EC 3.4.11.2,CD 13)和P(EC 3.4.11.9)以及羧肽酶M(EC 3.4.17.12)和P(EC 3.4.17.16),对它们的差异、受体亚型特异性激活或失活很重要。氨肽酶A和N从血管紧张素II生成血管紧张素III和IV。氨肽酶P从缓激肽和NPY释放末端氨基酸,产生Y2受体特异性激动剂NPY(2 - 36)。羧肽酶P产生AT II(1 - 7),羧肽酶M产生BK1受体激动剂[去-Arg9]缓激肽。因此,血管平滑肌细胞表面的肽酶对生物活性血管活性肽的水平产生复杂影响。

相似文献

1
Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells.血管平滑肌细胞中参与血管紧张素II、缓激肽、降钙素基因相关肽(CGRP)和神经肽Y代谢的蛋白酶。
Peptides. 1996;17(4):709-20. doi: 10.1016/0196-9781(96)00066-6.
2
Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides.
Biochem Pharmacol. 1985 Jul 1;34(13):2309-17. doi: 10.1016/0006-2952(85)90787-7.
3
Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts.
Peptides. 1995;16(8):1367-73. doi: 10.1016/0196-9781(95)02034-9.
4
Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV.二肽基肽酶IV对神经肽Y和肽YY的蛋白水解加工。
Regul Pept. 1993 Dec 10;49(2):133-44. doi: 10.1016/0167-0115(93)90435-b.
5
Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.神经肽:代谢为生物活性片段及其受体的药理学。
Med Res Rev. 2015 May;35(3):464-519. doi: 10.1002/med.21323. Epub 2014 Jun 3.
6
Metabolism and functions of neuropeptide Y.神经肽Y的代谢与功能
Neurochem Res. 1996 Sep;21(9):1125-32. doi: 10.1007/BF02532423.
7
Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle.骨骼肌中鉴定出的肽酶对血管紧张素和缓激肽的代谢作用。
Peptides. 1995;16(6):1073-8. doi: 10.1016/0196-9781(95)00082-u.
8
Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example.
Biochimie. 1994;76(3-4):283-7. doi: 10.1016/0300-9084(94)90159-7.
9
Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M.
Biochem Pharmacol. 1989 Jan 1;38(1):173-80. doi: 10.1016/0006-2952(89)90165-2.
10
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.神经肽Y(NPY)从头部到足部的蛋白水解降解:新型NPY裂解肽酶的鉴定以及中枢神经系统和外周潜在的药物相互作用。
J Neurochem. 2015 Dec;135(5):1019-37. doi: 10.1111/jnc.13378. Epub 2015 Nov 16.

引用本文的文献

1
Role of Neurotransmitters in Steady State Hematopoiesis, Aging, and Leukemia.神经递质在稳态造血、衰老和白血病中的作用。
Stem Cell Rev Rep. 2025 Jan;21(1):2-27. doi: 10.1007/s12015-024-10761-z. Epub 2024 Jul 8.
2
Structural basis of neuropeptide Y signaling through Y and Y receptors.神经肽Y通过Y受体和Y₂受体信号传导的结构基础。
MedComm (2020). 2024 Jun 15;5(7):e565. doi: 10.1002/mco2.565. eCollection 2024 Jul.
3
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance.二肽基肽酶-4抑制剂对肝脏疾病及相关糖耐量异常的潜在影响。
Diabetes Metab Syndr Obes. 2022 Jun 16;15:1845-1864. doi: 10.2147/DMSO.S369712. eCollection 2022.
4
Construction of calcitonin gene-related peptide-modified mesenchymal stem cells and analysis of their effects on the migration and proliferation of vascular smooth muscle cells.构建降钙素基因相关肽修饰的间充质干细胞并分析其对血管平滑肌细胞迁移和增殖的影响。
In Vitro Cell Dev Biol Anim. 2020 Feb;56(2):181-191. doi: 10.1007/s11626-019-00429-1. Epub 2020 Jan 7.
5
Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MS.微超高效液相色谱-串联质谱法测定人血浆中神经肽 Y 及其四种代谢物的含量。
Anal Chem. 2020 Jan 7;92(1):859-866. doi: 10.1021/acs.analchem.9b03505. Epub 2019 Dec 16.
6
Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells.神经肽 Y 调节造血干细胞和祖细胞的血管门户。
J Clin Invest. 2017 Dec 1;127(12):4527-4540. doi: 10.1172/JCI94687. Epub 2017 Nov 13.
7
Cutaneous Vasodilation during Local Heating: Role of Local Cutaneous Thermosensation.局部加热过程中的皮肤血管舒张:局部皮肤温度觉的作用。
Front Physiol. 2016 Dec 20;7:622. doi: 10.3389/fphys.2016.00622. eCollection 2016.
8
Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.肾细胞癌中神经肽水平以及中性内肽酶活性降低。
Cancer Microenviron. 2016 Dec;9(2-3):141-147. doi: 10.1007/s12307-016-0189-y. Epub 2016 Oct 19.
9
Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model.内肽酶和血管紧张素转换酶抑制剂可导致肌肉过度使用模型中形态变化的放大和 P 物质系统的上调。
BMC Musculoskelet Disord. 2014 Apr 11;15:126. doi: 10.1186/1471-2474-15-126.
10
A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.大脑 RAS 在阿尔茨海默病和帕金森病中的作用。
Front Endocrinol (Lausanne). 2013 Oct 25;4:158. doi: 10.3389/fendo.2013.00158.